Nymox Pharmaceutical Corp SMA 50
What is the SMA 50 of Nymox Pharmaceutical Corp?
The SMA 50 of Nymox Pharmaceutical Corp is $0 -12.25%
What is the definition of SMA 50?
SMA 50 is an average stock price from the last 50 days calculated as an unweighted mean of the previous 50 stock closing prices.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 of companies in the Health Care sector on NASDAQ compared to Nymox Pharmaceutical Corp
What does Nymox Pharmaceutical Corp do?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Companies with sma 50 similar to Nymox Pharmaceutical Corp
- Thermal International has SMA 50 of CAD$0 +5.15%
- Gome Finance Technology Co has SMA 50 of HKD$0 +38.84%
- Impac Mortgage has SMA 50 of $0 +0.70%
- European Metals has SMA 50 of AUD$0 -31.43%
- China Kangda Food has SMA 50 of HKD$0 -11.73%
- Yorkton Ventures has SMA 50 of CAD$0 +13.85%
- Nymox Pharmaceutical Corp has SMA 50 of $0 -12.25%
- Cosmos Machinery Enterprises has SMA 50 of HKD$0 -3.69%
- Komet Resources has SMA 50 of CAD$0 +94.96%
- Sierra Metals Inc has SMA 50 of $0 -9.92%
- Outcrop Gold has SMA 50 of CAD$0 -2.48%
- Defiance Silver has SMA 50 of CAD$0 +13.28%
- Modern Media has SMA 50 of HKD$0 -15.11%